Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1993 Apr;69(4):322–326. doi: 10.1136/hrt.69.4.322

Rapid increase in plasma endothelin concentrations during percutaneous balloon dilatation of the mitral valve in patients with mitral stenosis.

O Kinoshita 1, H Yoshimi 1, S Nagata 1, F Ishikura 1, K Kimura 1, T Yamabe 1, K Takagaki 1, K Miyatake 1, T Omae 1
PMCID: PMC1025045  PMID: 8489864

Abstract

OBJECTIVE--To investigate the relation between plasma concentrations of immunoreactive endothelin and haemodynamic variables before and after percutaneous transvenous balloon dilatation of the mitral valve. DESIGN--Prospective study. SETTING--National cardiovascular centre. PATIENTS--25 patients with mitral stenosis and 26 healthy volunteers. MAIN OUTCOME MEASURES--Plasma concentrations of immunoreactive endothelin were measured in the pulmonary artery, left atrium, ascending aorta, and femoral vein before and after balloon dilatation of the mitral valve. RESULTS--Peripheral venous concentrations (mean (SD)) of endothelin were higher in the patients with mitral stenosis than in the healthy volunteers (1.76 (0.51) v 1.37 (0.45) pg/ml, p < 0.05) and they correlated with the mean left atrial pressure (r = 0.74, p < 0.01). Balloon dilatation of the mitral valve reduced the mean left atrial pressure without changing the mean right atrial pressure, systemic arterial pressure, heart rate, or cardiac index. Concentrations of plasma endothelin in the femoral vein increased from 1.76 (0.51) to 3.39 (2.46) (p < 0.01), 4.82 (2.34) (p < 0.001), and 2.43 (0.52) pg/ml (p < 0.05) at 15 and 30 minutes and 24 hours after the procedure. The concentration of endothelin in the pulmonary artery also increased from 1.85 (0.85) to 4.32 (1.58) pg/ml (p < 0.01) 30 minutes after the dilatation, whereas there were no appreciable changes in endothelin concentration in the left atrium or ascending aorta. CONCLUSIONS--Plasma endothelin concentrations were higher in patients with mitral stenosis than in healthy volunteers and the increase was proportional to left atrial pressure. After balloon dilatation of the mitral valve there was an abrupt rise in endothelin in the femoral vein and pulmonary artery but no change in left atrial or aortic blood samples. These findings suggest that endothelin may be another vasoactive substance involved in congestive heart failure.

Full text

PDF
322

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cavero P. G., Miller W. L., Heublein D. M., Margulies K. B., Burnett J. C., Jr Endothelin in experimental congestive heart failure in the anesthetized dog. Am J Physiol. 1990 Aug;259(2 Pt 2):F312–F317. doi: 10.1152/ajprenal.1990.259.2.F312. [DOI] [PubMed] [Google Scholar]
  2. Cernacek P., Stewart D. J. Immunoreactive endothelin in human plasma: marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun. 1989 Jun 15;161(2):562–567. doi: 10.1016/0006-291x(89)92636-3. [DOI] [PubMed] [Google Scholar]
  3. Emori T., Hirata Y., Ohta K., Shichiri M., Marumo F. Secretory mechanism of immunoreactive endothelin in cultured bovine endothelial cells. Biochem Biophys Res Commun. 1989 Apr 14;160(1):93–100. doi: 10.1016/0006-291x(89)91625-2. [DOI] [PubMed] [Google Scholar]
  4. Ferguson D. W., Abboud F. M., Mark A. L. Selective impairment of baroreflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation. 1984 Mar;69(3):451–460. doi: 10.1161/01.cir.69.3.451. [DOI] [PubMed] [Google Scholar]
  5. Inoue K., Owaki T., Nakamura T., Kitamura F., Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984 Mar;87(3):394–402. [PubMed] [Google Scholar]
  6. Ishikura F., Nagata S., Hirata Y., Kimura K., Nakatani S., Tamai J., Yamagishi M., Ohmori F., Beppu S., Takamiya M. Rapid reduction of plasma atrial natriuretic peptide levels during percutaneous transvenous mitral commissurotomy in patients with mitral stenosis. Circulation. 1989 Jan;79(1):47–50. doi: 10.1161/01.cir.79.1.47. [DOI] [PubMed] [Google Scholar]
  7. Kitamura K., Tanaka T., Kato J., Eto T., Tanaka K. Regional distribution of immunoreactive endothelin in porcine tissue: abundance in inner medulla of kidney. Biochem Biophys Res Commun. 1989 May 30;161(1):348–352. doi: 10.1016/0006-291x(89)91603-3. [DOI] [PubMed] [Google Scholar]
  8. Kohno M., Yasunari K., Murakawa K., Yokokawa K., Horio T., Fukui T., Takeda T. Plasma immunoreactive endothelin in essential hypertension. Am J Med. 1990 Jun;88(6):614–618. doi: 10.1016/0002-9343(90)90527-k. [DOI] [PubMed] [Google Scholar]
  9. MacCumber M. W., Ross C. A., Glaser B. M., Snyder S. H. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc Natl Acad Sci U S A. 1989 Sep;86(18):7285–7289. doi: 10.1073/pnas.86.18.7285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mancia G., Donald D. E. Demonstration that the atria, ventricles, and lungs each are responsible for a tonic inhibition of the vasomotorcenter in the dog. Circ Res. 1975 Feb;36(2):310–318. doi: 10.1161/01.res.36.2.310. [DOI] [PubMed] [Google Scholar]
  11. Margulies K. B., Hildebrand F. L., Jr, Lerman A., Perrella M. A., Burnett J. C., Jr Increased endothelin in experimental heart failure. Circulation. 1990 Dec;82(6):2226–2230. doi: 10.1161/01.cir.82.6.2226. [DOI] [PubMed] [Google Scholar]
  12. Masaoka H., Suzuki R., Hirata Y., Emori T., Marumo F., Hirakawa K. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet. 1989 Dec 9;2(8676):1402–1402. doi: 10.1016/s0140-6736(89)92019-9. [DOI] [PubMed] [Google Scholar]
  13. Nunez D. J., Brown M. J., Davenport A. P., Neylon C. B., Schofield J. P., Wyse R. K. Endothelin-1 mRNA is widely expressed in porcine and human tissues. J Clin Invest. 1990 May;85(5):1537–1541. doi: 10.1172/JCI114601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sahn D. J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 Dec;58(6):1072–1083. doi: 10.1161/01.cir.58.6.1072. [DOI] [PubMed] [Google Scholar]
  15. Shichiri M., Hirata Y., Ando K., Emori T., Ohta K., Kimoto S., Ogura M., Inoue A., Marumo F. Plasma endothelin levels in hypertension and chronic renal failure. Hypertension. 1990 May;15(5):493–496. doi: 10.1161/01.hyp.15.5.493. [DOI] [PubMed] [Google Scholar]
  16. Shichiri M., Hirata Y., Ando K., Kanno K., Emori T., Ohta K., Marumo F. Postural change and volume expansion affect plasma endothelin levels. JAMA. 1990 Feb 2;263(5):661–661. [PubMed] [Google Scholar]
  17. Stewart D. J., Levy R. D., Cernacek P., Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991 Mar 15;114(6):464–469. doi: 10.7326/0003-4819-114-6-464. [DOI] [PubMed] [Google Scholar]
  18. Toyo-oka T., Aizawa T., Suzuki N., Hirata Y., Miyauchi T., Shin W. S., Yanagisawa M., Masaki T., Sugimoto T. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation. 1991 Feb;83(2):476–483. doi: 10.1161/01.cir.83.2.476. [DOI] [PubMed] [Google Scholar]
  19. Wagner O. F., Nowotny P., Vierhapper H., Waldhäusl W. Plasma concentrations of endothelin in man: arterio-venous differences and release during venous stasis. Eur J Clin Invest. 1990 Oct;20(5):502–505. doi: 10.1111/j.1365-2362.1990.tb01892.x. [DOI] [PubMed] [Google Scholar]
  20. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group. Lancet. 1990 Jul 7;336(8706):1–6. [PubMed] [Google Scholar]
  21. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988 Mar 31;332(6163):411–415. doi: 10.1038/332411a0. [DOI] [PubMed] [Google Scholar]
  22. Yoshimi H., Hirata Y., Fukuda Y., Kawano Y., Emori T., Kuramochi M., Omae T., Marumo F. Regional distribution of immunoreactive endothelin in rats. Peptides. 1989 Jul-Aug;10(4):805–808. doi: 10.1016/0196-9781(89)90117-4. [DOI] [PubMed] [Google Scholar]
  23. Yoshimi H., Inoue I., Hirata Y., Kojima S., Kuramochi M., Ito K., Sakakibara H., Omae T. Atrial natriuretic peptide secretion in mitral stenosis. Am J Cardiol. 1987 Aug 1;60(4):396–397. doi: 10.1016/0002-9149(87)90260-8. [DOI] [PubMed] [Google Scholar]
  24. Zehr J. E., Hasbargen J. A., Kurz K. D. Reflex suppression of renin secretion during distention of cardiopulmonary receptors in dogs. Circ Res. 1976 Apr;38(4):232–239. doi: 10.1161/01.res.38.4.232. [DOI] [PubMed] [Google Scholar]
  25. Zucker I. H., Earle A. M., Gilmore J. P. The mechanism of adaptation of left atrial stretch receptors in dogs with chronic congestive heart failure. J Clin Invest. 1977 Aug;60(2):323–331. doi: 10.1172/JCI108780. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. de Nucci G., Thomas R., D'Orleans-Juste P., Antunes E., Walder C., Warner T. D., Vane J. R. Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9797–9800. doi: 10.1073/pnas.85.24.9797. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES